Abstract
Background: The aim of this study was to evaluate immunohistochemical markers in pancreatic cancer and to determine the association of their expression with clinico-pathological features and prognosis. Patients and Methods: Thirty pancreatic adenocarcinoma patients were followed-up for an average period of 5 years. FAS, bcl-2, p53 and Ki-67 expression were detected immunohistochemically to determine their prognostic value. Results: FAS was statistically associated with p53 (p=0.002), Ki-67 (p=0.003), higher histological grade (p=0.001 and recurrence and overall survival (p=0.001). Conclusion: The newly found overexpression of FAS in highly aggressive pancreatic carcinomas may help us stratify patients into different prognostic groups and indicate new therapeutic strategies.
Footnotes
- Received February 6, 2007.
- Revision received April 23, 2007.
- Accepted April 30, 2007.
- Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved





